Nishant K Mishra on Preventing Post-Stroke Seizures
Nishant K Mishra, Stroke Director at U.S. Department of Veterans Affairs, shared on LinkedIn:
”Delighted to share our thoughts on treatment and prevention strategies for post stroke epilepsy”
Stroke is the leading cause of new-onset seizures and epilepsy in older adults and is linked to higher morbidity and mortality.
Post-stroke seizures are classified as early or late, depending on whether they occur within or after 7 days of the stroke, with a single late seizure sufficient to diagnose post-stroke epilepsy.
This review outlines current strategies for diagnosing and managing post-stroke seizures, highlighting levetiracetam and lamotrigine as potentially preferred options for reducing acute seizure recurrence despite limited evidence.
It also emphasizes the lack of data on several other agents and suggests that future research, particularly into biomarkers of epileptogenesis, could enable more practical and informative clinical trials.
Read the full article here.
Article: Pharmacological strategies for preventing post-stroke seizures and epilepsy
Authors: Yuki Kawamura, Eugen Trinka, Terence J. Quinn, Hedley C. A. Emsley, Johan Zelano, Tomotaka Tanaka, Masafumi Ihara, Lauren H. Sansing, David S. Liebeskind, Nishant K Mishra
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 12, 2026, 14:27Moustafa Abdou: Paroxysmal Nocturnal Hemoglobinuria From a Rare Disease to a Treatable Condition
-
Apr 12, 2026, 14:18Jean Jacques Kiladjian: Grateful to the MSH for the invitation to ‘Highlights of ASH’ in Asia-Pacific 2026
-
Apr 12, 2026, 14:15Paritosh Garg: A fibrotic marrow is not always PMF
-
Apr 12, 2026, 14:13Scott Woller: ACC/AHA Guidelines and the Role of Pulmonary Embolism Response Teams
-
Apr 12, 2026, 13:55Ifeanyichukwu Ifechidere: When Fibrinogen isn’t Really Fibrinogen
-
Apr 12, 2026, 13:53Alan Nurden: A Contemporary Update on the Pathogenesis of Inherited Platelet Dysfunction
-
Apr 12, 2026, 13:47Kalyan Roy: Visual Inspection of Blood Bags and Blood Products
-
Apr 12, 2026, 13:44Francisco Ujueta: PAD VS CAD – Why Individualized Antithrombotic Strategies Matter
-
Apr 12, 2026, 13:42William Aird: Anemia of Inflammation Not Just a Trade-Off but a Possible Compensation